Coronavirus outbreak: The countries affected
The 2019 novel coronavirus (2019-nCoV), officially named as Covid-19 by the WHO, has spread to 34 more countries apart from...
Trending menu:
-
![Coronavirus in South Korea: Outbreak, measures and impact]()
Coronavirus in South Korea: Outbreak, measures and impact
-
![Coronavirus treatment: Vaccines/drugs in the pipeline for Covid-19]()
Coronavirus treatment: Vaccines/drugs in the pipeline for Covid-19
-
![Coronavirus in Thailand: dealing with the 2019-nCoV (Covid-19) outbreak and impact]()
Coronavirus in Thailand: dealing with the 2019-nCoV (Covid-19) outbreak and impact
-
![Coronavirus in Malaysia: Covid-19 outbreak, measures and impact]()
Coronavirus in Malaysia: Covid-19 outbreak, measures and impact
-
![Coronavirus in China: the outbreak, measures, and impact]()
Coronavirus in China: the outbreak, measures, and impact
-
![Coronavirus in Philippines: The Covid-19 risk, impact and measures]()
Coronavirus in Philippines: The Covid-19 risk, impact and measures
Expert commentary & analysis from GlobalData
Coronavirus in India: how the 2019-nCoV could impact the fast-growing economy
Coronavirus in the UK: Measures and impact of Covid-19
Coronavirus outbreak: Countries that have tested negative
Coronavirus: Countries with suspected cases
Most Read
Company releases
SOM Biotech: A Top Spanish Start-Up to Follow in 2020
SOM Biotech has made Sifted's list as one of the Top Spanish Start-ups to follow in 2020.
Programme SOM0208 for the Treatment of Niemann–Pick Type C Disease
Programme SOM1311 for the Treatment of Phenylketonuria
SOM1311 is a small molecule pharmacological chaperone of Phenylalanine Hydroxylase for the treatment of Phenylketonuria.
Programme SOM3355 to Treat Chorea in Huntington Sisease and Tardive Dyskinesia
Partnership Programme to Identify Drugs Effective for Therapeutic Areas of Interest
SOMAI PRO Technology is a proprietary AI-based drug discovery technology of SOM Biotech. It is...
Company whitepapers
Laboratorios Planes’ Product Catalogue
Laboratorios PlanesPartnership presentation
SOM BiotechBeyond Electronic Data Capture
niAnalyticsAtreMorine: A Biotechnological / Nutraceutical product for Parkinson’s
EuroEspes BiotechnologyStudy: Pharmacokinetics of Oral Cyanocobalamin Formulated with SNAC
Emisphere TechnologiesIoT Tracking and Monitoring
OnAsset IntelligenceUnderstanding Sucrose: Matching Sucrose Quality to Functional Need
PfanstiehlCompany A-Z
Clinical Trials
NGM Bio’s aldafermin shows favourable profile in Phase II NASH study
NGM Biopharmaceuticals has reported positive data from the fourth cohort of a Phase II clinical trial of aldafermin in non-alcoholic steatohepatitis (NASH) patients.
United Therapeutics’ Tyvaso meets goals in PH-ILD patients
Bristol-Myers initiates new cohort in Phase I/II trial of BMS-986249
Sojournix starts clinical trial of SJX-653 for menopausal hot flashes
ReNeuron’s hRPC stem cell therapy yields positive results
Drug Development
Zelira reports positive data from cannabis trial in insomnia
Australia-based Zelira Therapeutics has reported positive results from the Phase Ib/IIa clinical trial of cannabis drug candidate ZLT-101 in patients with chronic insomnia.
Alnylam closes enrolment in Phase III trial of vutrisiran
Recardio to continue Phase II trial of dutogliptin
China approves first anti-viral drug against coronavirus Covid-19
BMS reports Phase III data of Opdivo plus Yervoy in renal cancer
Your recommended content
Measuring wellbeing programmes for impact and returns
Download a free 10 page preview of our Mergers & Acquisitions in TMT – Thematic Research 2019 Report
Go Top